Skip to main content
Premium Trial:

Request an Annual Quote

Applied Gene Technologies to Develop TB Diagnostic for AsiaGen

SAN FRANCISCO, Nov. 5 – Applied Gene Technologies has entered a development, manufacturing, and marketing deal with Taiwanese biopharmaceutical company AsiaGen, the companies announced Monday.

Applied Gene Technologies, based in San Diego, will develop tuberculosis diagnostics using its Tessera Array Technology for AsiaGen, which received exclusive rights to manufacture and market the product in Asia.

Applied Gene Technologies will receive an upfront payment for the development work, according to the company. Details of the payment were not disclosed.

Applied Gene Technologies’ Tessera Arrays analyze patient samples of nucleic acids to detect a sequence of target marker genes for infectious organisms. The technology utilizes reverse hybridization to identify an organism after a single hybridization, according to the company.

“Over three million deaths a year are caused by tuberculosis in Asia,” Nani Dattagupta, chief scientific officer of Applied Gene Technologies, said in a statement. “Our diagnostics will help save lives by detecting those that have been exposed to the tuberculosis bacteria more accurately and efficiently, allowing treatment at an earlier stage. Our relationship with AsiaGen will further accelerate the development of new diagnostics using our Tessera Array Technology.”

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.